Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

LivaNova PLC

LIVN Clue Score47
United Kingdom Fiscal year ends December CIK 0001639691 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ahmet Tezel
11 Aug 2026
Chief Innovation Officer
Sold after exercise
2,675
$77.74
$207.94K
Francesco Bianchi
15 Jun 2026
Director
Sold after exercise
1,200
$80.19
$96.23K
Daniel Jeffrey Moore
3 Jun 2024
Director
Sold after exercise
2,045
$61.09
$124.92K
Daniel Jeffrey Moore
3 Jun 2024
Director
Sold after exercise
54,578
$60.08
$3.28M
Daniel Jeffrey Moore
29 Jun 2021
Director
Sold after exercise
1,000
$84.20
$84.20K
Marco Dolci
18 May 2021
SVP Global Operations, R&D
Sold after exercise
1,019
$83.23
$84.81K
Marco Dolci
18 May 2021
SVP Global Operations, R&D
Sold after exercise
7,259
$82.87
$601.52K
Daniel Jeffrey Moore
15 Dec 2018
Director
Sold after exercise
1,000
$91.85
$91.85K
Douglas John Manko
15 Aug 2018
Chief Accounting Officer
Sold after exercise
2,058
$121.61
$250.28K
Damien McDonald
8 Jun 2018
CEO
Sold after exercise
15,742
$96.51
$1.52M

What was left out

Form 4 filings counted 417
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 10
Sales at will 86
Transactions with no price 0
Shares from compensation/vesting 1,339,486
Sales filed before the plan box existed 78
History held since 18 Nov 2015